Duopharma Biotech Bhd (7148) — Strategic Asset Allocation Index
Duopharma Biotech Bhd (7148) has a Strategic Asset Allocation Index of 73.1% as of December 2025. Strategic assets (PP&E of RM554.08 Million plus long-term investments of RM-) total RM554.08 Million, measured against net assets of RM757.62 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Duopharma Biotech Bhd Strategic Asset Allocation Index (2016–2024)
This chart shows how Duopharma Biotech Bhd's Strategic Asset Allocation Index has evolved across 9 annual periods from 2016 to 2024. As of December 2025, the index stands at 73.1%, representing strategic assets of RM554.08 Million against net assets of RM757.62 Million MYR. Explore 7148 cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Duopharma Biotech Bhd (2016–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Duopharma Biotech Bhd from 2016 to 2024, covering 9 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see 7148 market cap overview.
| Year | SAAI | Strategic Assets (MYR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 80.0% | RM567.52 Million | RM567.52 Million | RM- | RM709.15 Million | ▼ -4.7 pp |
| 2023 | 84.8% | RM582.37 Million | RM582.37 Million | RM- | RM687.12 Million | ▼ -3.8 pp |
| 2022 | 88.5% | RM579.92 Million | RM579.92 Million | RM- | RM655.22 Million | ▲ +1.4 pp |
| 2021 | 87.1% | RM543.44 Million | RM543.44 Million | RM- | RM624.00 Million | ▲ +18.5 pp |
| 2020 | 68.6% | RM441.79 Million | RM441.79 Million | RM- | RM643.82 Million | ▼ -9.2 pp |
| 2019 | 77.8% | RM412.25 Million | RM412.25 Million | RM- | RM529.75 Million | ▼ -2.5 pp |
| 2018 | 80.3% | RM386.18 Million | RM386.18 Million | RM- | RM481.04 Million | ▲ +13.3 pp |
| 2017 | 67.0% | RM321.33 Million | RM321.33 Million | RM- | RM479.87 Million | ▲ +6.2 pp |
| 2016 | 60.8% | RM276.24 Million | RM276.24 Million | RM- | RM454.52 Million | — |